PEPFAR

PEPFAR

PEPFAR committed to work with countries on a system of shared data and rotating locations for implementation studies; to develop a proposal for further expediting the regulatory approval process; and to fund the procurement of only optimal paediatric ARVs.

Document (s)

Sub-action PEPFAR.3

To fund the procurement of only optimal paediatric ARVs.

see action 9.

Document (s)

Milestone PEPFAR.3.1

Milestone PEPFAR.2.1

Sub-action PEPFAR.1

PEPFAR committed to work with countries on a system of shared data and rotating locations for implementation studies

PEPFAR has developed a website that makes program data available for review and analysis: https://data.pepfar.net/ PEPFAR is developing a mechanism for addressing requests from external stakeholders and partners for more detailed program data to use in important analyses.

PEPFAR has not yet developed sites for implementation studies.

Milestone PEPFAR.1.1

Document (s)

Committed by:

Sub-Actions & Milestones

PEPFAR and FDA have been working on mechanisms that would enable making FDA review documents available to WHO and/or national drug regulatory authorities for tentatively approved products to facilitate more timely regulatory approval of those products for use in PEPFAR-supported HIV programs.

PEPFAR has also been working with WHO in advance of the upcoming WHO Guidelines meeting to advance optimal ARV regimens for children.

Sub-action PEPFAR.2

To develop a proposal for further expediting the regulatory approval process

Updates

Notes

Responsible